World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
45849
World Ranking
6989
National Ranking
3676

Overview

Wilbur A. Franklin is affiliated with the University of Colorado Denver in the United States. Their research concentrates primarily within the field of Medicine, with a focus on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research, Surgery, and Artificial Intelligence.

The scientist's work addresses several key topics, including:

  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Genomics and Diagnostics
  • Colorectal and Anal Carcinomas
  • AI in cancer detection
  • Genetic factors in colorectal cancer

Wilbur A. Franklin has contributed to multiple publications, with notable papers including:

  • Multi-Institutional Prospective Validation of Prognostic mRNA Signatures in Early Stage Squamous Lung Cancer (Alliance), 2020, Journal of Thoracic Oncology
  • Lung Cancer Recurrence Risk Prediction through Integrated Deep Learning Evaluation, 2022, Cancers
  • Lung cancer: Premalignant biology and medical prevention, 2022, Seminars in Oncology
  • Prevalence, molecular markers, and outcome of bronchial squamous carcinoma in situ in high-risk subjects, 2023, Apmis
  • Analysis of Orthologous Gene Expression between Human Pulmonary Adenocarcinoma and a Carcinogen-Induced Murine Model, 2020, UNC Libraries

Frequent co-authors collaborating with Wilbur A. Franklin include:

  • Paul A. Bunn
  • Daniel T. Merrick
  • David S. Ettinger
  • Dara L. Aisner
  • Kurtis D. Davies

Publication venues where Wilbur A. Franklin's research has appeared include:

  • Journal of Thoracic Oncology
  • Cancers
  • Seminars in Oncology
  • Apmis
  • UNC Libraries

Best Publications

  • International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

    William D Travis;Elisabeth Brambilla;Masayuki Noguchi;Andrew G Nicholson

  • Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer

    Federico Cappuzzo;Fred R. Hirsch;Elisa Rossi;Stefania Bartolini

  • Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    Mark G. Kris;Bruce E. Johnson;Lynne D. Berry;David J. Kwiatkowski

  • Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

    Fred R. Hirsch;Marileila Varella-Garcia;Paul A. Bunn;Michael V. Di Maria

  • The national lung screening trial: Overview and study design

    Constantine A. Gatsonis;Denise R. Aberle;Christine D. Berg;William C. Black

  • Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non-Small Cell Lung Cancer

    Robert C. Doebele;Amanda B. Pilling;Dara L. Aisner;Tatiana G. Kutateladze

  • Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer

    Fred R. Hirsch;Marileila Varella-Garcia;Paul A. Bunn;Wilbur A. Franklin

  • Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study

    Fred R. Hirsch;Marileila Varella-Garcia;Jason McCoy;Howard West

  • Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers

    Alex A. Adjei;Roger B. Cohen;Wilbur Franklin;Clive Morris

  • Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior.

    Thorgeir E Thorgeirsson;Daniel F Gudbjartsson;Ida Surakka;Ida Surakka;Jacqueline M Vink

  • Early Detection of Lung Cancer: Clinical Perspectives of Recent Advances in Biology and Radiology

    Fred R. Hirsch;Wilbur A. Franklin;Adi F. Gazdar;Paul A. Bunn

  • Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

    Samir E. Witta;Robert M. Gemmill;Fred R. Hirsch;Christopher D. Coldren

  • Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.

    E J Shpall;R B Jones;S I Bearman;W A Franklin

  • Diagnosis of Lung Cancer in Small Biopsies and Cytology: Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification

    William D. Travis;Elisabeth Brambilla;Masayuki Noguchi;Andrew G. Nicholson

  • Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis.

    Wilbur A. Franklin;Adi F. Gazdar;Adi F. Gazdar;Jerry Haney;Ignacia I. Wistuba

  • Promoter Hypermethylation of Multiple Genes in Sputum Precedes Lung Cancer Incidence in a High-Risk Cohort

    Steven A. Belinsky;Kieu C. Liechty;Frederick D. Gentry;Holly J. Wolf

  • Increased HER2 Gene Copy Number Is Associated With Response to Gefitinib Therapy in Epidermal Growth Factor Receptor–Positive Non–Small-Cell Lung Cancer Patients

    Federico Cappuzzo;Marileila Varella-Garcia;Hisayuki Shigematsu;Irene Domenichini

  • Multi-institutional oncogenic driver mutation analysis in lung adenocarcinoma: The lung cancer mutation consortium experience

    Lynette M. Sholl;Dara L. Aisner;Marileila Varella-Garcia;Lynne D. Berry

  • High-Throughput Tissue Microarray Analysis Used to Evaluate Biology and Prognostic Significance of the E-Cadherin Pathway in Non–Small-Cell Lung Cancer

    Roy M. Bremnes;R. Veve;E. Gabrielson;F. R. Hirsch

  • A Major Lung Cancer Susceptibility Locus Maps to Chromosome 6q23–25

    J. E. Bailey-Wilson;C. I. Amos;S. M. Pinney;G. M. Petersen

Frequent Co-Authors

Paul A. Bunn
Paul A. Bunn University of Colorado Boulder
Fred R. Hirsch
Fred R. Hirsch Mount Sinai Hospital
Anna E. Barón
Anna E. Barón University of Colorado Anschutz Medical Campus
D. Ross Camidge
D. Ross Camidge University of Colorado Anschutz Medical Campus
David R. Gandara
David R. Gandara University of California, Davis
John D. Minna
John D. Minna The University of Texas Southwestern Medical Center
Elizabeth J. Shpall
Elizabeth J. Shpall The University of Texas MD Anderson Cancer Center
John Crowley
John Crowley Washington University in St. Louis
Ignacio I. Wistuba
Ignacio I. Wistuba The University of Texas MD Anderson Cancer Center
Bruce E. Johnson
Bruce E. Johnson Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers in the USA opens doors to a variety of related online degrees and alternative pathways. For those interested in entering healthcare fields quickly, training in online medical billing and coding with financial aid offers a fast, flexible route into administrative medical roles while minimizing financial barriers.

If you’re looking for healthcare programs without standardized exam requirements, you might consider nursing programs without teas. These programs allow students to bypass typical entry exams, making the process more accessible.

Managing hospitals or healthcare systems is another rewarding path. The demand for qualified leaders is growing, and you can earn a healthcare administration accelerated degree to fast-track your entry into this field.

For current nurses aiming to advance, specialized bridge programs like asn to nurse practitioner programs enable a seamless transition to higher qualifications and expanded roles.

Best Scientists Citing Wilbur A. Franklin

Trending Scientists